MCID: HMN010
MIFTS: 57

Hemangioma malady

Categories: Genetic diseases (common), Cancer diseases

Aliases & Classifications for Hemangioma

About this section

Aliases & Descriptions for Hemangioma:

Name: Hemangioma 32 10 47 12 36 65

Classifications:



External Ids:

Disease Ontology10 DOID:255
ICD1027 D18.0, D18.00, D18
ICD9CM29 228.0, 228.00
MeSH36 D006391
NCIt42 C3085
UMLS65 C0018916

Summaries for Hemangioma

About this section
Disease Ontology:10 A cell type benign neoplasm that has physical basis in endothelial cells that line blood vessels and is characterised by increased number of normal or abnormal vessels filled with blood.

MalaCards based summary: Hemangioma is related to hemangioma, capillary infantile and hemangioma thrombocytopenia syndrome. An important gene associated with Hemangioma is KDR (Kinase Insert Domain Receptor), and among its related pathways are VEGF ligand-receptor interactions and Transcription_P53 signaling pathway. The drugs interferon alfa-2a and interferon alfa-2b have been mentioned in the context of this disorder. Affiliated tissues include endothelial, brain and liver, and related mouse phenotypes are no phenotypic analysis and liver/biliary system.

Wikipedia:68 A hemangioma is a benign and usually self-involuting tumor (swelling or growth) of the endothelial cells... more...

Related Diseases for Hemangioma

About this section

Diseases in the Hemangioma family:

Acquired Hemangioma Hemangioma, Hereditary
Familial Hemangioma

Diseases related to Hemangioma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 1242)
idRelated DiseaseScoreTop Affiliating Genes
1hemangioma, capillary infantile34.3ANTXR1, FLT4, KDR
2hemangioma thrombocytopenia syndrome33.9FLT4, PROX1
3gastric adenocarcinoma30.6PTEN, VEGFA
4hydrocephalus30.4KRIT1, TEK
5placenta accreta30.0FLT4, SLC2A1, TEK
6lymphoblastic lymphoma29.9FLT4, KDR, PROX1
7gliosarcoma29.9KDR, KRAS, PTEN, VEGFA
8chronic venous insufficiency29.7FGF2, HIF1A, KDR, VEGFA
9renal cell carcinoma29.7FLT4, HIF1A, KDR, KRAS, PTEN, SLC2A1
10medulloepithelioma29.6PDPN, PROX1, SLC2A1
11lung cancer29.5FGF2, FLT4, HIF1A, KDR, KRAS, NKX2-1
12hepatocellular carcinoma29.5ANGPT2, FGF2, HIF1A, KDR, PTEN, VEGFA
13myoma29.3FLT4, LYVE1, PDPN, PROX1, VEGFA
14capillary hemangioma12.4
15non-involuting congenital hemangioma12.4
16cavernous hemangioma12.3
17glomeruloid hemangioma12.3
18sclerosing hemangioma12.3
19bone epithelioid hemangioma12.3
20rapidly involuting congenital hemangioma12.2
21intracranial structure hemangioma12.2
22hemangioma of intra-abdominal structure12.2
23hemangioma of spleen12.2
24intramuscular hemangioma12.2
25skin hemangioma12.2
26histiocytoid hemangioma12.2
27spindle cell hemangioma12.2
28central nervous system hemangioma12.2
29pulmonary sclerosing hemangioma12.2
30supraumbilical midabdominal raphe and facial cavernous hemangiomas12.2
31hemangioma of subcutaneous tissue12.2
32skin epithelioid hemangioma12.2
33hemangioma of liver12.2
34gastric hemangioma12.2
35venous hemangioma12.2
36hemangioma of lung12.2
37hobnail hemangioma12.2
38giant hemangioma12.2
39cavernous hemangioma of colon12.2
40breast epithelioid hemangioma12.2
41verrucous keratotic hemangioma12.1
42breast hemangioma12.1
43acquired hemangioma12.1
44breast capillary hemangioma12.1
45dandy-walker malformation with facial hemangioma12.1
46sacral hemangiomas multiple congenital abnormalities12.1
47transverse limb deficiency hemangioma12.1
48congenital liver hemangioma12.1
49retinal cavernous hemangioma12.1
50hemangioma of orbit12.1

Graphical network of the top 20 diseases related to Hemangioma:



Diseases related to hemangioma

Symptoms for Hemangioma

About this section

Drugs & Therapeutics for Hemangioma

About this section

Drugs for Hemangioma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 177)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
MethylprednisoloneapprovedPhase 4, Phase 3, Phase 2108283-43-26741
Synonyms:
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
.DELTA.1-6.alpha.-Methylhydrocortisone
1-Dehydro-6alpha-methylhydrocortisone
1-dehydro-6alpha-Methylhydrocortisone
1-dehydro-6α-methylhydrocortisone
11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
121673-01-6
4-08-00-03498 (Beilstein Handbook Reference)
46436_FLUKA
46436_RIEDEL
570-35-4
6 Methylprednisolone
6-Methylprednisolone
6-alpha-Methylprednisolone
6.alpha.-Methylprednisolone
6923-42-8
6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
83-43-2
A-methapred
AC1L1N7A
Artisone-Wyeth
Artisone-wyeth
BPBio1_000174
BRD-K35240538-001-03-1
BRN 2340300
BSPBio_000158
Besonia
Bio-0658
CHEBI:6888
CHEMBL650
CID6741
CPD000058330
D00407
D008775
DB00959
Depo-Medrol (acetate)
Depo-medrol
Dopomedrol
EINECS 201-476-4
Esametone
Firmacort
HMS1568H20
HMS2090B13
HSDB 3127
LMST02030178
LS-118498
Lemod
M0639_SIGMA
M1665
MEPRDL
MLS000028541
MLS001148159
MLS002207191
Medesone
Medixon
Medlone 21
 
Medrate
Medrol
Medrol (TN)
Medrol Adt Pak
Medrol Dosepak
Medrol adt pak
Medrol dosepak
Medrol, Solu-Medrol, Medrone, Methylprednisolone
Medrone
Mesopren
Metastab
Methyleneprednisolone
Methylprednisolon
Methylprednisolone
Methylprednisolone (JP15/USP/INN)
Methylprednisolone [USAN:INN:BAN:JAN]
Methylprednisolone, 6-alpha
Methylprednisolonum
Methylprednisolonum [INN-Latin]
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [DCIT]
Metilprednisolone [Dcit]
Metipred
Metrisone
Metrocort
Metysolon
Moderin
MolPort-002-528-554
NCGC00022735-03
NCI60_001657
NSC-19987
NSC19987
Nirypan
Noretona
Predni N Tablinen
Prednol- L
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI)
Prestwick0_000279
Prestwick1_000279
Prestwick2_000279
Prestwick3_000279
Prestwick_622
Promacortine
Reactenol
S1733_Selleck
SAM002589984
SMR000058330
SPBio_002377
Sieropresol
Solomet
Solu-medrol
Summicort
Suprametil
U 7532
UNII-X4W7ZR7023
Urbason
Urbasone
Wyacort
ZINC03875560
delta(1)-6alpha-Methylhydrocortisone
delta(sup 1)-6-alpha-Methylhydrocortisone
methylprednisolone
methylprenisolone
2
PrednisoloneapprovedPhase 4, Phase 3, Phase 2108250-24-85755
Synonyms:
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
.DELTA.1-Cortisol
.DELTA.1-Dehydrocortisol
.DELTA.1-Dehydrohydrocortisone
.DELTA.1-Hydrocortisone
.delta.-Cortef
.delta.-Stab
1,2-Dehydrohydrocortisone
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1-Dehydrocortisol
1-Dehydrohydrocortisone
3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene
46656_FLUKA
46656_RIEDEL
50-24-8
58201-11-9
8056-11-9
AC-1773
AC1L1L2E
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
BPBio1_000164
BRD-K98039984-001-03-0
BRN 1354103
BSPBio_000148
Bio-0666
Bubbli-Pred
C07369
CCRIS 980
CHEBI:8378
CHEMBL131
CID5755
CO-Hydeltra
CPD000718761
Co-Hydeltra
Codelcortone
Cordrol
Cortalone
Cotogesic
Cotolone
D00472
D011239
DB00860
Decaprednil
Decortin H
Delcortol
Delta F
Delta(1)-dehydrohydrocortisone
Delta-Cortef
Delta-Cortef (TN)
Delta-Ef-Cortelan
Delta-Stab
Delta-stab
Deltacortenol
Deltacortril
Deltacortril Enteric
Deltahydrocortisone
Deltasolone
Deltisilone
Depo-Medrol
Derpo PD
Derpo Pd
Dexa-Cortidelt Hostacortin H
Dexa-Cortidelt hostacortin H
Di Adreson F
Di-Adreson F
Di-Adreson-F
Di-adreson F
DiAdresonF
Dicortol
Donisolone
Dydeltrone
EINECS 200-021-7
Eazolin D
Econopred
Econopred Plus
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
Fernisolone-P
Flamasone
Flo-pred
HMS1568H10
HMS2090J05
HSDB 3385
Hostacortin H
Hydeltra
Hydeltra-Tba
Hydeltrasol
Hydeltrone
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
Hydroretrocortine
I-Pred
Inflamase Forte
Inflamase Mild
K 1557
Key-Pred
Klismacort
LMST02030179
LS-7669
Lentosone
Lite Pred
M-Predrol
MLS001304083
 
MLS002154250
MLS002207037
Medrol
Medrol Acetate
Metacortandralone
Methylprednisolone Acetate
Meti-Derm
Meticortelone
Metreton
Millipred
MolPort-002-507-147
NCGC00179649-01
NSC 9120
NSC9120
NSC9900
Neo-Delta-Cortef
Nisolone
Nor-Pred T.B.A.
Ocu-Pred
Ocu-Pred Forte
Omnipred
Ophtho-Tate
Orapred
P0152_SIGMA
P0637
P6004_SIGMA
PRDL
PRED-G
Panafcortelone
Paracortol
Paracotol
Pediapred
Poly-Pred
Precortalon
Precortancyl
Precortilon
Precortisyl
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
Predisolone Sodium Phosphate
Predne-Dome
Prednelan
Predni-Dome
Prednicen
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
Prednisolone
Prednisolone (JP15/USP/INN)
Prednisolone (anhydrous)
Prednisolone Acetate
Prednisolone Sodium Phosphate
Prednisolone Tebutate
Prednisolone [INN:BAN:JAN]
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
Prelone
Prenolone
Prestwick0_000274
Prestwick1_000274
Prestwick2_000274
Prestwick3_000274
Prestwick_404
Rolisone
S1737_Selleck
SAM002264639
SMR000718761
SPBio_002367
Scherisolon
Solone
Steran
Sterane
Sterolone
Supercortisol
UNII-9PHQ9Y1OLM
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-Hydrogen
Ultracortene-hydrogen
ZINC03833821
component of Ataraxoid
component of K-Predne-Dome
delta(1)-Cortisol
delta(1)-Dehydrocortisol
delta(1)-Dehydrohydrocortisone
delta(1)-Hydrocortisone
delta(sup 1)-Cortisol
delta(sup 1)-Dehydrocortisol
delta(sup 1)-Dehydrohydrocortisone
delta(sup 1)-Hydrocortisone
delta-dehydrocortisol
delta-dehydrohydrocortisone
delta-hydrocortisone
prednisolone
3
Propranololapproved, investigationalPhase 4, Phase 2, Phase 3, Phase 1202525-66-64946
Synonyms:
(+-)-Propranolol
(1)-1-(Isopropylamino)-3-(naphthyloxy)propan-2-ol
(R)-(+)-propranolol
(S)-(-)-PROPRANOLOL
1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol
1-(1-Naphthyloxy)-2-hydroxy-3-(isopropylamino)propane
1-(Isopropylamino)-3-(1-naphthoxy)-propan-2-ol
1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol
1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol
1-(naphthalen-1-yloxy)-3-(propan-2-ylamino)propan-2-ol
1-Isopropylamino-3-(1-naphthyloxy)-2-propanol
1-[(1-methylethyl)amino]-3-(naphthalen-1-yloxy)propan-2-ol
1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol
13013-17-7
2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)- (9CI)
2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)-, (+-)- (9CI)
3-(naphthalen-1-yloxy)-1-(propan-2-ylamino)propan-2-ol
4199-09-1
4199-10-4
525-66-6
AB00053537
AC1L1JA4
AC1Q1QBV
AC1Q1QC0
AKOS000588816
AY 64043
AY-20694
Anaprilin
Anapriline
Angilol
Apsolol
Avlocardyl
BPBio1_001040
BRD-A10070317-003-06-9
BSPBio_000944
BSPBio_002682
Bedranol
Beprane
Berkolol
Beta Neg
Beta-Neg
Beta-Propranolol
Beta-Tablinen
Beta-Timelets
Betachron
Betadren
Betalong
Bio-0732
Bio1_000367
Bio1_000856
Bio1_001345
C07407
C16H21NO2
CBDivE_006180
CCRIS 3082
CHEBI:8499
CHEMBL27
CID4946
Cardinol
Caridolol
Corpendol
D,L-Propranolol
D08443
DB00571
DL-Propranolol hydrochloride
Deralin
DivK1c_000023
Dl-Propranolol Hydrochloride
Dociton
Duranol
EINECS 208-378-0
EINECS 235-867-6
Efektolol
Elbrol
Etalong
Euprovasin
Frekven
HMS2090L21
Hemangeol
Herzbase
ICI 45520
IDI1_000023
INDERIDE-40/25
INDERIDE-80/25
Ikopal
Inderal
Inderal LA
Inderal La
Inderal hydrochloride
Inderalici
Inderex
Inderide
Inderol
Indobloc
 
Innopran XL
Innopran Xl
Intermigran
KBio1_000023
KBio2_002515
KBio2_005083
KBio2_007651
KBio3_001766
KBio3_001902
KBio3_002993
KBioGR_001347
KBioGR_001684
KBioGR_002515
KBioSS_002523
Kemi
Kemi S
L000679
LS-122410
LS-184129
Lopac0_000896
Migrastat
MolPort-001-794-623
NCGC00015798-07
NCGC00024690-02
NCGC00024690-03
NINDS_000023
NSC91523
Naprilin
Obsidan
Obzidan
Oposim
Oprea1_304193
PDSP1_000767
PDSP1_001607
PDSP1_001608
PDSP2_000755
PDSP2_001591
PDSP2_001592
Prano-Puren
Pranolol
Prestwick0_000952
Prestwick1_000952
Prestwick2_000952
Prestwick3_000952
Pronovan
Propanalol
Propanix
Propanolol
Propanolol [INN-Spanish]
Prophylux
Propranalol
Propranolol
Propranolol (INN)
Propranolol (TN)
Propranolol Hcl
Propranolol Hcl Intensol
Propranolol Hydrochloride
Propranolol [INN:BAN]
Propranololo
Propranololo [DCIT]
Propranololum
Propranololum [INN-Latin]
Propranur
Proprasylyt
Pylapron
R,S-Propranolol Hydrochloride
Racemic propranolol
Rapynogen
Reducor
Reducor Line
Reducor line
SPBio_001361
SPBio_001658
SPBio_003093
STK735510
Sagittol
Sawatal
Servanolol
Sloprolol
Spectrum2_001301
Spectrum2_001699
Spectrum3_000883
Spectrum3_001071
Spectrum4_000974
Spectrum4_001222
Spectrum5_000751
Sumial
Tesnol
UNII-9Y8NXQ24VQ
b-Propranolol
beta-Propranolol
cMAP_000071
etalong
propranolol
propranololo
β-Propranolol
4
Sufentanilapproved, investigationalPhase 415356030-54-741693
Synonyms:
56030-54-7
60561-17-3 (citrate)
AC1L26AJ
AC1Q5I7B
C08022
C22H30N2O2S
CHEBI:127638
CHEBI:9316
CHEMBL658
CID41693
Chronogesic
D05938
DB00708
HSDB 6760
L000580
LS-175693
MolPort-004-286-008
N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidinyl)-N-phenylpropanamide
N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)propionanilide
 
N-[4-(methoxymethyl)-1-(2-thiophen-2-ylethyl)piperidin-4-yl]-N-phenylpropanamide
N-{4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]piperidin-4-yl}-N-phenylpropanamide
N-{4-[(methyloxy)methyl]-1-[2-(2-thienyl)ethyl]piperidin-4-yl}-N-phenylpropanamide
Oprea1_120838
Oprea1_246787
PDSP1_001741
PDSP2_001724
R 30730
R-30730
SUFENTANIL
Sufentanil
Sufentanil (USAN/INN)
Sufentanil Citrate
Sufentanil [USAN:BAN:INN]
Sufentanilo
Sufentanilum
Sufentanilum [INN-Latin]
Sufentanyl
Sulfentanil
Sulfentanyl
UNII-AFE2YW0IIZ
5
DexmedetomidineapprovedPhase 4470113775-47-668602, 5311068, 56032
Synonyms:
(+)-4-((S)-alpha,2,3-Trimethylbenzyl)imidazole
(+)-4-((S)-alpha,2,3-trimethylbenzyl)imidazole
(+)-medetomidine
(S)-medetomidine
113775-47-6
4-[(1S)-1-(2,3-Dimethylphenyl)ethyl]-1H-imidazole
4-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole
5-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole
AC1NSJXT
C07450
CHEBI:4466
CHEMBL778
CID5311068
D00514
DEXMEDETOMIDINE
Dexdor (T)
 
Dexmedetomidin
Dexmedetomidina
Dexmedetomidine
Dexmedetomidine (USAN/INN)
Dexmedetomidine Hydrochloride
Dexmedetomidinum
Dexmédétomidine
MPV 1440
MPV-1440
Medetomidina [Spanish]
Medetomidine
Medetomidinum [Latin]
NCGC00025347-01
PRECEDEX
Precedex
Precedex (TN)
Tocris-2023
ZINC04632106
6parecoxibexperimentalPhase 439119828
7Peripheral Nervous System AgentsPhase 4, Phase 3, Phase 218510
8Adrenergic AgentsPhase 4, Phase 2, Phase 3, Phase 1, Phase 04204
9Neurotransmitter AgentsPhase 4, Phase 2, Phase 3, Phase 1, Phase 014795
10Prednisolone acetatePhase 4, Phase 3, Phase 21082
11Prednisolone phosphatePhase 4, Phase 3, Phase 21082
12AnestheticsPhase 47385
13Vasodilator AgentsPhase 4, Phase 2, Phase 3, Phase 12926
14Neuroprotective AgentsPhase 4, Phase 3, Phase 21376
15Prednisolone hemisuccinatePhase 4, Phase 3, Phase 21082
16Protective AgentsPhase 4, Phase 3, Phase 25651
17Adrenergic beta-AntagonistsPhase 4, Phase 2, Phase 3, Phase 1, Phase 0979
18Anti-Inflammatory AgentsPhase 4, Phase 3, Phase 28478
19Anti-Arrhythmia AgentsPhase 4, Phase 2, Phase 3, Phase 1, Phase 02371
20Antihypertensive AgentsPhase 4, Phase 2, Phase 3, Phase 1, Phase 03618
21Methylprednisolone HemisuccinatePhase 4, Phase 3, Phase 21082
22AntiemeticsPhase 4, Phase 3, Phase 23213
23Adrenergic AntagonistsPhase 4, Phase 2, Phase 3, Phase 1, Phase 01253
24Antineoplastic Agents, HormonalPhase 4, Phase 3, Phase 24256
25Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 4, Phase 3, Phase 29988
26Methylprednisolone acetatePhase 4, Phase 3, Phase 21082
27HormonesPhase 4, Phase 3, Phase 211748
28Hormone AntagonistsPhase 4, Phase 3, Phase 210002
29Gastrointestinal AgentsPhase 4, Phase 3, Phase 26401
30glucocorticoidsPhase 4, Phase 3, Phase 23896
31Cyclooxygenase 2 InhibitorsPhase 4538
32Cyclooxygenase InhibitorsPhase 42225
33Antirheumatic AgentsPhase 48496
34AnalgesicsPhase 49358
35Analgesics, Non-NarcoticPhase 45184
36Anti-Inflammatory Agents, Non-SteroidalPhase 43549
37Central Nervous System DepressantsPhase 410016
38NarcoticsPhase 42709
39Hypnotics and SedativesPhase 42032
40Anesthetics, IntravenousPhase 41943
41Anesthetics, GeneralPhase 42274
42Adrenergic alpha-2 Receptor AgonistsPhase 4790
43Adrenergic AgonistsPhase 42331
44Adrenergic alpha-AgonistsPhase 41300
45Analgesics, OpioidPhase 42304
46
NadololapprovedPhase 3, Phase 22142200-33-939147
Synonyms:
(2R,3S)-5-(3-(tert-Butylamino)-2-hydroxypropoxy)-1,2,3,4-tetrahydronaphthalene-2,3-diol
(2R,3S)-5-({3-[(1,1-dimethylethyl)amino]-2-hydroxypropyl}oxy)-1,2,3,4-tetrahydronaphthalene-2,3-diol
(2R,3S)-5-[3-(tert-butylamino)-2-hydroxypropoxy]-1,2,3,4-tetrahydronaphthalene-2,3-diol
2,3-cis-1,2,3,4-Tetrahydro-5-((2-hydroxy-3-tert-butylamino)propoxy)-2,3-naphthalenediol
42200-33-9
5-(3-((1,1-Dimethylethyl)amino)-2-hydroxypropoxy)-1,2,3,4-tetrahydro-2,3-naphthalenediol
AC1L2151
AC1Q1MO3
AC1Q77IZ
Anabet
BRD-A87606379-001-03-4
BSPBio_003152
CCRIS 1048
CHEMBL649
CID39147
CPD000058975
Corgard
Corgard (TN)
Corgaretic
D00432
D009248
DB01203
DivK1c_000427
EINECS 255-706-3
HMS1570D17
HMS1922O05
HMS2093A15
HMS501F09
HSDB 6532
IDI1_000427
KBio1_000427
KBio2_002123
KBio2_004691
KBio2_007259
KBio3_002652
 
KBioGR_000765
KBioSS_002123
LS-94578
MLS000028580
MLS001148087
MolPort-003-666-474
NCGC00089811-02
NINDS_000427
Nadic
Nadolol
Nadolol (JP15/USP/INN)
Nadolol [USAN:BAN:INN:JAN]
Nadololum
Nadololum [INN-Latin]
Prestwick0_000818
Prestwick1_000818
Prestwick2_000818
Prestwick_108
SAM002264627
SMP1_000203
SMR000058975
SPBio_001392
SPBio_002636
SPECTRUM1503260
SQ 11725
SQ-11725
SQ11725
Solgol
Spectrum2_001546
Spectrum3_001586
Spectrum4_000193
Spectrum5_001255
Spectrum_001643
UNII-FEN504330V
VU0239635-6
nadolol
47
TimololapprovedPhase 3, Phase 2, Phase 1, Phase 023626839-75-833624, 5478
Synonyms:
(-)-3-Morpholino-4-(3-tert-butylamino-2-hydroxypropoxy)-1,2,5-thiadiazole
(2S)-1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-2-propanol
(2S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
(2S)-1-[(1,1-dimethylethyl)amino]-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
(S)-1-(1,1-(Dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-2-propanol
(S)-1-(tert-Butylamino)-3-((4-morpholino-1,2,5-thiadiazol-3-yl)oxy)propan-2-ol
(S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
(S)-timolol
131628-37-0
194288-09-0
26839-75-8
26921-17-5 (maleate (1:1) salt)
AB00513729
AC1L1PYN
AC1Q59QM
Apo-Timol
Apo-Timop
Aquanil
BIDD:GT0073
BPBio1_001008
BRD-K08806317-050-03-6
BSPBio_000916
Betim
Betimol
Betimol (TN)
Blocadren
C07141
C13H24N4O3S
CAS-26921-17-5
CHEBI:9599
CHEMBL499
CID33624
CPD001456519
D08600
DB00373
DB08625
EINECS 248-032-6
HMS2089I11
HSDB 6533
Istalol
L-714,465
LS-122231
Lopac-T-6394
Lopac0_001189
MK-950
NCGC00016038-01
NCGC00016038-02
 
NCGC00016798-01
NCGC00016798-07
NCGC00022033-02
NCGC00022033-04
NCGC00022033-05
Novo-Timol
Nu-Timolol
Oprea1_640981
Optimol
Phoxal-timolol
Prestwick0_000948
Prestwick1_000948
Prestwick2_000948
Prestwick3_000948
Proflax
S(-)-Timolol maleate
S-(-)-3-(3-tert-Butylamino-2-hydroxypropoxy)-4-morpholino-1,2,5-thiadiazole
SAM002564238
SPBio_003075
ST072193
TIM
Temserin
Tenopt
Tim-AK
Timacar
Timacor
Timolol
Timolol (INN)
Timolol (TN)
Timolol GFS
Timolol Maleate
Timolol Maleate, (1:1) Salt
Timolol [USAN]
Timolol hemihydrate
Timolol maleate
Timololo
Timololum
Timololum [INN-Latin]
Timopic
Timoptic
Timoptic OcuDose
Timoptic in Ocudose
Timoptic-XE
Timoptic-xe
Timoptol
Tocris-0649
UNII-817W3C6175
timolol
48
PseudoephedrineapprovedPhase 344790-82-47028
Synonyms:
( )-Pseudoephedrine
(+)-(1S,2S)-Pseudoephedrine
(+)-Pseudoephedrine
(+)-Psi-ephedrine
(+)-psi-Ephedrine
(+)-threo-Ephedrine
(1S,2S)-(+)-Pseudoephedrine
(1S,2S)-2-(methylamino)-1-phenylpropan-1-ol
(1S,2S)-2-Methylamino-1-phenyl-1-propanol
(1S,2S)-Pseudoephedrine
(1S,2S)-Pseudoephedrine, polymer-bound
1-Ephedrine
2-(Methylamino)-1-phenyl-1-propanol
287636_ALDRICH
304-87-0
30987-59-8
37577-31-4
649031_ALDRICH
90-82-4
AC-20292
AC1L1NUA
Acunaso
Acunaso (TN)
Afrinol
BIDD:GT0817
BRD-K84175871-003-02-2
BSPBio_003261
Balminil Decongestant Syrup
Benylin Decongestant
Benzenemethanol, alpha-((1S)-1-(methylamino)ethyl)-, (alpha-S)- (9CI)
Besan
C02765
C10H15NO
CHEBI:51209
CHEMBL1590
CID7028
CPD-9954
Cenafed
D-Isoephedrine
D-Pseudoephedrine
D-Pseudoephedrine base
D-Psi-2-Methylamino-1-phenyl-1-propanol
D-Psi-2-methylamino-1-phenyl-1-propanol
D-Psi-Ephedrine
D-Psi-ephedrine
D08449
DB00852
Decofed
Dimetapp Decongestant
Dimetapp Decongestant Pediatric Drops
DivK1c_000451
Drixoral N.D.
Drixoral Nasal Decongestant
EINECS 202-018-6
Efidac 24 Pseudoephedrine Hcl
Efidac/24
Eltor 120
Ephed 60
Ephedrine
Genaphed
HSDB 3177
I01-8928
IDI1_000451
Isoephedrine
KBio1_000451
 
KBio2_001358
KBio2_003926
KBio2_006494
KBio3_002762
KBioGR_001763
KBioSS_001358
L(+)-Psi-Ephedrine
L(+)-Psi-ephedrine
L(+)-psi-Ephedrine
L-(+)-Pseudoephedrine
LS-125922
Lopac-E-3250
Maxenal
MolPort-001-684-474
Myfedrine
NCGC00015408-01
NCGC00178180-01
NCI60_002955
NINDS_000451
Neodurasina
Neodurasina (TN)
Novafed
PDSP1_001347
PSEUDOEPHEDRINE
Pedia Care
Pseudo
Pseudo 60's
Pseudo-12
Pseudoefedrina
Pseudoefedrina [INN-Spanish]
Pseudoephedrine
Pseudoephedrine (D)
Pseudoephedrine (INN)
Pseudoephedrine D-form
Pseudoephedrine Ephedrine
Pseudoephedrine Hydrochloride
Pseudoephedrine [INN:BAN]
Pseudoephedrine d-form
Pseudoephedrine hydrochloride
Pseudoephedrine sulfate
Pseudoephedrinum
Pseudoephedrinum [INN-Latin]
Psi-ephedrin
Psi-ephedrine
Robidrine
SPBio_001365
STOCK1N-42675
Spectrum2_001303
Spectrum3_001771
Spectrum4_001162
Spectrum5_000650
Spectrum_000878
Sudafed
Sudafed Decongestant
Sudafed Decongestant 12 Hour
Sudafed Decongestant Extra Strength
Suphedrine
Triaminic AM Decongestant Formula
Triaminic Infant Oral Decongestant Drops
UNII-7CUC9DDI9F
alpha-(1-(Methylamino)ethyl)benzyl alcohol
d-Isoephedrine
d-Pseudoephedrine
d-psi-2-Methylamino-1-phenyl-1-propanol
d-psi-Ephedrine
trans-Ephedrine
49
AtenololapprovedPhase 39929122-68-72249
Synonyms:
( inverted question mark)-Atenolol
(+-)-4-(2-Hydroxy-3-isopropylaminopropoxy)phenylacetamide
(+-)-Atenolol
(+/-)-4-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzeneacetamide
(1)-2-(4-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide
(?)-Atenolol
1-p-Carbamoylmethylphenoxy-3-isopropylamino-2-propanol
2-(4-(2-Hydroxy-3-isopropylaminopropoxy)phenyl)acetamid
2-(4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}phenyl)acetamide
2-(p-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide
2-[4-(2-Hydroxy-3-isopropylaminopropoxy)phenyl]acetamide
2-[4-({2-hydroxy-3-[(1-methylethyl)amino]propyl}oxy)phenyl]acetamide
2-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]acetamide
2-{4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl}acetamide
29122-68-7
4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)benzeneacetamide
4-[2 -Hydroxy-3 -(isopropylamino)-propoxy]phenylacetamide
4-[2'-Hydroxy-3'-(isopropylamino)propoxy]phenylacetamide
60966-51-0
A 7655
A7655_SIGMA
AC-11142
AC1L1D99
AC1Q1QBX
AKOS005111050
ARONIS23884
Acetamide,2-(p-(2-hydroxy-3-(isopropylamino)propoxy)phenyl)
Aircrit
Alinor
Altol
Anselol
Antipressan
Apo-Atenolol
Atcardil
Atecard
Atehexal
Atenblock
Atendol
Atenet
Ateni
Atenil
Atenol
Atenol 1A Pharma
Atenol 1A pharma
Atenol AL
Atenol Acis
Atenol Atid
Atenol CT
Atenol Cophar
Atenol Fecofar
Atenol GNR
Atenol Gador
Atenol Genericon
Atenol Heumann
Atenol MSD
Atenol NM Pharma
Atenol Nordic
Atenol PB
Atenol Quesada
Atenol Stada
Atenol Tika
Atenol Trom
Atenol Von CT
Atenol acis
Atenol ct
Atenol von ct
Atenol-Mepha
Atenol-Ratiopharm
Atenol-Wolff
Atenol-ratiopharm
Atenolin
Atenolol
Atenolol (JAN/USP)
Atenolol (JP15/USP/INN)
Atenolol [USAN:BAN:INN:JAN]
Atenolol [USAN:INN:BAN:JAN]
Atenololum
Atenololum [INN-Latin]
Atenomel
Atereal
Aterol
BB_SC-1519
BIM-0050109.0001
BRD-A20239487-001-02-5
BRN 2739235
BSPBio_002915
Betablok
Betacard
Betasyn
Betatop GE
Betatop Ge
Blocotenol
Blokium
CCRIS 4196
CHEBI:2904
CHEMBL24
CID2249
CPD000036768
Cardaxen
Cardiopress
Corotenol
Cuxanorm
D001262
D00235
DB00335
DivK1c_000057
Duraatenolol
Duratenol
 
EINECS 249-451-7
EINECS 262-544-7
EU-0100121
Evitocor
Farnormin
Felo-Bits
HMS1569L13
HMS1921H09
HMS2090I19
HMS2092D19
HMS500C19
HSDB 6526
Hipres
Hypoten
I01-3572
ICI 66,082
ICI 66082
ICI-66082
ICI66082
IDI1_000057
Ibinolo
InChI=1/C14H22N2O3/c1-10(2)16-8-12(17)9-19-13-5-3-11(4-6-13)7-14(15)18/h3-6,10,12,16-17H,7-9H2,1-2H3,(H2,15,18)
Internolol
Jenatenol
Juvental
KBio1_000057
KBio2_001844
KBio2_004412
KBio2_006980
KBio3_002415
KBioGR_000790
KBioSS_001844
L000116
LS-28557
LS-9707
Lo-Ten
Lo-ten
Lopac0_000121
Loten
Lotenal
MLS000069622
MLS001066372
MLS001074163
MLS001304038
MolPort-001-792-717
Myocord
NCGC00015007-07
NCGC00015007-13
NCGC00024566-03
NCGC00024566-04
NCGC00024566-05
NCGC00024566-06
NCGC00024566-07
NINDS_000057
Neatenol
Normalol
Normiten
Noten
Oprea1_448775
Oraday
Ormidol
Panapres
Plenacor
Premorine
Prenolol
Prenormine
Prinorm
SAM002564193
SMR000036768
SPBio_001482
SPECTRUM1501127
STK528649
Scheinpharm Atenol
Seles Beta
Seles beta
Selobloc
Serten
Servitenol
Spectrum2_001411
Spectrum3_001448
Spectrum4_000435
Spectrum5_001509
Spectrum_001364
Stermin
Tenidon
Teno-Basan
Teno-basan
Tenobloc
Tenoblock
Tenolol
Tenoprin
Tenoretic
Tenormin
Tenormin (TN)
Tenormine
Tenormine [French]
Tensimin
Tensotin
Tredol
UNII-50VV3VW0TI
Unibloc
Uniloc
Vascoten
Vericordin
Wesipin
Xaten
atenolol
benzeneacetamide, 4-[2'-hydroxy-3
duratenol
50
EphedrineapprovedPhase 3447299-42-39294
Synonyms:
( )-Pseudoephedrine
(+)-Ephedrin
(+)-Ephedrine
(+)-Pseudoephedrine
(+)-psi-Ephedrine
(+)-threo-Ephedrine
(+-)-Ephedrine
(-)-Ephedrine
(-)-Pseudoephedrine
(-)-psi-Ephedrine
(-)-threo-Ephedrine
(1R,2R)-Ephedrine
(1R,2S)-1-Phenyl-1-hydroxy-2-methylaminopropane
(1S,2R)-Ephedrine
(L)-EPHEDRINE
--EPHEDRINE
1-EPHEDRINE
1-Sedrin
134910_ALDRICH
287636_ALDRICH
287644_ALDRICH
299-42-3
304-87-0
30987-59-8
321-96-0
321-97-1
321-98-2
37577-31-4
38732-95-5
45261_FLUKA
4607-45-8
50-98-6
50906-05-3
53214-57-6
649031_ALDRICH
6912-63-6
7009-81-6
90-82-4
968-63-8
AC-20231
AC-20292
AC1L1JGK
AC1L1NUA
AC1L1RFA
AC1L1SR1
AC1L1T31
AC1L1Y3M
AC1O8JUO
AC1Q3XJE
AC1Q3XJM
AC1Q3XJN
AC1Q59F5
AC1Q7701
AI3-02761
AKOS000268842
AR-1A0126
AR-1I7143
Acunaso
Acunaso (TN)
Afrinol
Ambap299-42-3
BIDD:GT0817
BRN 3197916
BRN 4231286
BSPBio_001946
BSPBio_001968
BSPBio_003261
Benylin Decongestant
Besan
Biophedrin
C01575
C02765
C10H15NO
CHEBI:15407
CHEBI:51209
CHEMBL1590
CHEMBL211456
CHEMBL357080
CID11972440
CID5032
CID62946
CID6710657
CID7028
CID8650
CID9294
CID9457
CPD-9954
CPDD 0049
Cenafed
D00124
D08449
DB00852
DB01364
Decofed
DivK1c_000181
DivK1c_000451
DivK1c_000461
Drixoral N.D.
EINECS 202-017-0
EINECS 202-018-6
EINECS 206-080-5
EINECS 206-292-8
EINECS 206-293-3
Eciphin
Efedrin
Efidac/24
Eltor 120
Ephedral
Ephedremal
Ephedrin
Ephedrine
Ephedrine (TN)
Ephedrine (USP)
Ephedrine [USAN:BAN]
Ephedrine l-form
Ephedrital
Ephedrol
Ephedrosan
Ephedrotal
Ephedsol
Ephendronal
Ephoxamin
Fedrin
Genaphed
HSDB 3072
HSDB 3177
I-Sedrin
I01-3584
I01-8925
I01-8928
 
IDI1_000181
IDI1_000451
IDI1_000461
Isoephedrine
Jsp005664
KBio1_000181
KBio1_000451
KBio1_000461
KBio2_001358
KBio2_001500
KBio2_003926
KBio2_004068
KBio2_006494
KBio2_006636
KBio3_001188
KBio3_001446
KBio3_002762
KBioGR_001013
KBioGR_001763
KBioSS_001358
KBioSS_001500
KST-1A9168
Kratedyn
L(+)-psi-Ephedrine
L(-)-Ephedrine
L-(+)-Ephedrine
L-(-)-Ephedrine
L-Ephedrine
L-erythro-2-(Methylamino)-1-phenylpropan-1-ol
L000968
LS-125921
LS-125922
LS-43083
LS-63961
LS-63962
LS-63963
LS-63964
Lexofedrin
Lopac-E-3250
Lopac0_000501
MLS000069657
Manadrin
Mandrin
Maxenal
MolPort-001-684-474
MolPort-001-684-477
MolPort-001-684-478
MolPort-001-684-479
MolPort-001-769-085
Myfedrine
NCGC00015408-01
NCGC00015408-02
NCGC00162174-01
NCGC00178180-01
NCGC00178889-01
NCI-C55652
NCI60_002955
NINDS_000181
NINDS_000451
NINDS_000461
NSC 165609
NSC 170951
NSC 8971
NSC165609
NSC170951
NSC8971
Nasol
Neodurasina
Neodurasina (TN)
Oprea1_287330
PDSP1_000168
PDSP1_001106
PDSP1_001343
PDSP1_001345
PDSP1_001346
PDSP1_001347
PDSP2_000167
PDSP2_001090
PDSP2_001327
PDSP2_001329
PDSP2_001330
PDSP2_001331
PSEUDOEPHEDRINE
Pedia Care
Pseudo
Pseudo 60's
Pseudo-12
Pseudoefedrina
Pseudoephedrine (D)
Pseudoephedrinum
Psi-ephedrin
Psi-ephedrine
Robidrine
SMR000059174
SPBio_000214
SPBio_001365
SPBio_001377
ST023802
STK367993
STOCK1N-42675
Sanedrine
Spectrum2_000137
Spectrum2_001303
Spectrum2_001309
Spectrum3_000414
Spectrum3_000563
Spectrum3_001771
Spectrum4_000497
Spectrum4_001162
Spectrum5_000650
Spectrum5_000879
Spectrum5_001106
Spectrum_000878
Spectrum_001020
Sudafed
Sudafed Decongestant
UNII-03VRY66076
UNII-7CUC9DDI9F
UNII-GN83C131XS
Vencipon
WLN: QYR & Y1 & M1
WLN: QYR&Y1&M1
Zephrol
d-Ephedrine
d-Isoephedrine
d-Pseudoephedrine
d-psi-Ephedrine
l-Ephedrine
l-Pseudoephedrine
racephedrine
trans-Ephedrine

Interventional clinical trials:

(show top 50)    (show all 157)
idNameStatusNCT IDPhase
1The Safety and Efficiency of Propranolol as an Initial Treatment for Pediatric HemangiomaCompletedNCT01908972Phase 4
2Role of Parecoxib Sodium for Postoperative Pain Management in Open HepatectomyRecruitingNCT02204878Phase 4
3Apollo™ Onyx™ Delivery Micro Catheter Post Market Safety StudyRecruitingNCT02378883Phase 4
4Stereotactic Body Radiotherapy for Spine TumorsActive, not recruitingNCT01347307Phase 4
5Effect of Dexmedetomidine Combined With Sufentanil for Postoperative Intravenous Analgesia in NeurosurgeryNot yet recruitingNCT02552459Phase 4
6Visceral Artery Aneurysm Embolization by the Penumbra Ruby™ Coil SystemNot yet recruitingNCT02079818Phase 4
7Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic TherapyCompletedNCT01056341Phase 2, Phase 3
8Pulse Steroids Versus Oral Steroids in Problematic Hemangiomas of InfancyCompletedNCT00312520Phase 3
9Evaluation of Vertebroplasty Associated With Radiotherapy for Spine Metastases (EVAR)CompletedNCT00267033Phase 3
10A Multicenter, Open-label Study for E7040 in Japanese Subjects With Hypervascular Tumor and Subjects With Arteriovenous MalformationCompletedNCT01677624Phase 3
11A Randomized Trial of Unruptured Brain AVMsCompletedNCT00389181Phase 3
12Nadolol Versus Propranolol in Children With Infantile HemangiomasRecruitingNCT02505971Phase 3
13Efficacy and Safety of Propranolol Versus Acebutolol on the Proliferative Phase of Infantile HemangiomaRecruitingNCT01743885Phase 3
14Topical Timolol for Superficial Infantile HemangiomaRecruitingNCT01685398Phase 3
15CyberKnife Based Hypofractionated Radiotherapy for Vertebral HemangiomasRecruitingNCT02332408Phase 3
16Efficacy and Safety of Propranolol Versus Atenolol on the Proliferative Phase of Infantile HemangiomaRecruitingNCT02342275Phase 3
17Treatment of Port Wine Stains in Children With Pulsed Dye Laser and Timolol GelRecruitingNCT01272609Phase 3
18Functional Magnetic Resonance Imagine(fMRI)Navigation in Intracranial Arteriovenous Malformation SurgeryRecruitingNCT01758211Phase 3
19Propranolol in Capillary HemangiomasTerminatedNCT00744185Phase 2, Phase 3
20A Phase II Study of Imiquimod 5 % Cream for the Treatment of Hemangioma in InfancyCompletedNCT00601016Phase 2
21Nadolol for Proliferating Infantile HemangiomasCompletedNCT01010308Phase 2
22Study in Infants With Infantile Hemangioma to Compare Propranolol Gel to PlaceboCompletedNCT01512173Phase 2
23Comparative Study of the Use of Beta Blocker and Oral Corticosteroid in the Treatment of Infantile HemangiomaCompletedNCT01072045Phase 2
24The Effects of Aldara as an Adjunct to Laser TreatmentCompletedNCT00979550Phase 2
25Measurement Skin Temperature During Pulsed Laser ExposureCompletedNCT00540917Phase 2
26Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable MeningiomaCompletedNCT00589784Phase 2
27Treatment of Von Hippel-Lindau (VHL)-Related Hemangioblastoma With PTK787/ZK 222584CompletedNCT00052013Phase 2
28Study Comparing Onyx and TRUFILL in Brain Arteriovenous Malformations (AVMs)CompletedNCT00857662Phase 2
29Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal BleedingCompletedNCT00389935Phase 2
30Efficacy and Safety Study of Topical Rapamycin Associated With Pulsed Dye Laser in Patients With Sturge-Weber SyndromeCompletedNCT02080624Phase 2
31Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic SarcomaCompletedNCT01154452Phase 1, Phase 2
32Topical Timolol for Infantile Hemangioma in Early Proliferative PhaseRecruitingNCT02731287Phase 2
33A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular TumorsRecruitingNCT02110069Phase 2
34Efficacy of a Timolol Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) - Randomized Trial Versus PlaceboRecruitingNCT02484716Phase 2
35Prospective Evaluation of the Efficacy of Sirolimus (Rapamune®) in the Treatment of Severe Arteriovenous MalformationsRecruitingNCT02042326Phase 2
36Gemcitabine Hydrochloride With or Without Pazopanib Hydrochloride in Treating Patients With Refractory Soft Tissue SarcomaRecruitingNCT01532687Phase 2
37Safety and Efficacy Study of Sirolimus in Complicated Vascular AnomaliesActive, not recruitingNCT00975819Phase 2
38Treatment of Resistant Port-wine Stains With Bosentan and Pulsed Dye Laser: a Pilot StudyActive, not recruitingNCT02317679Phase 2
39A Study of Spinal RadiosurgeryActive, not recruitingNCT00573872Phase 1, Phase 2
40Cannabidiol Expanded Access Study in Medically Refractory Sturge-Weber SyndromeActive, not recruitingNCT02332655Phase 1, Phase 2
41Topical Timolol Gel for the Treatment of Infantile HemangiomasNot yet recruitingNCT02145884Phase 1, Phase 2
42Atorvastatin Therapy in Cerebral Cavernous Malformation: A Proof of Concept Phase I/II TrialNot yet recruitingNCT02603328Phase 1, Phase 2
43Dose-Finding of Propranolol in Combination With Metronomic Fixed Oral Cyclophosphamide Based on Bivariate Efficacy-tolerability Outcome in Patients With Locally Advanced or Metastatic Angiosarcoma: A Collaborative and Innovative Phase I-II Sequential TriaNot yet recruitingNCT02732678Phase 1, Phase 2
44Propranolol Versus Prednisolone for Treatment of Symptomatic HemangiomasTerminatedNCT00967226Phase 2
45Clinical Trial of Vincristine vs. Prednisolone for Treatment of Complicated HemangiomasTerminatedNCT00555464Phase 2
46Corticosteroids With Placebo Versus Corticosteroids With Propranolol Treatment of Infantile Hemangiomas (IH)TerminatedNCT01074437Phase 2
47Sunitinib Malate to Treat Advanced Eye Disease in Patients With Von Hippel-Lindau SyndromeTerminatedNCT00673816Phase 1, Phase 2
48Evaluation of Sunitinib Malate in Patients With Von Hippel-Lindau Syndrome (VHL) Who Have VHL Lesions to FollowTerminatedNCT00330564Phase 2
49Timolol Option for Ulcerated Hemangiomas (TOUCH Trial)WithdrawnNCT01408056Phase 2
50Adjunctive Everolimus (RAD 001) Therapy for Epilepsy in Children With Sturge-Weber Syndrome (SWS)WithdrawnNCT01997255Phase 2

Search NIH Clinical Center for Hemangioma

Inferred drug relations via UMLS65/NDF-RT43:


Cochrane evidence based reviews: hemangioma

Genetic Tests for Hemangioma

About this section

Anatomical Context for Hemangioma

About this section

MalaCards organs/tissues related to Hemangioma:

33
Endothelial, Brain, Liver, Breast, Skin, Bone, Lung

LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database

Cells/anatomical compartments in embryo or adult related to Hemangioma:
id TissueAnatomical CompartmentCell Relevance
1 HeartCardinal VeinsVenous Endothelial Cells Affected by disease

Animal Models for Hemangioma or affiliated genes

About this section

MGI Mouse Phenotypes related to Hemangioma:

38 (show all 20)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00030129.3ANTXR1, FLT4, KDR, KRAS, NKX2-1, SLC2A1
2MP:00053709.0FLT4, HIF1A, KDR, KRAS, PROX1, PTEN
3MP:00020068.6ANTXR1, FGF2, HIF1A, KRAS, KRIT1, NKX2-1
4MP:00107718.3ANGPT2, FLT4, HIF1A, KDR, KRAS, PDPN
5MP:00053808.1ANGPT1, FLT4, HIF1A, KDR, KRAS, KRIT1
6MP:00028738.0ACTC1, FLT4, HIF1A, KDR, KRAS, NKX2-1
7MP:00053817.9ANGPT2, FLT4, HIF1A, KRAS, NKX2-1, PDPN
8MP:00053887.6ANGPT2, HIF1A, KDR, KRAS, NKX2-1, PDPN
9MP:00053907.6ANTXR1, FGF2, HIF1A, KDR, KRAS, NKX2-1
10MP:00053917.5ANGPT1, ANGPT2, FGF2, HIF1A, KDR, KRAS
11MP:00053867.5FGF2, HIF1A, KDR, KRAS, NKX2-1, PDPN
12MP:00036317.3ANGPT1, FGF2, HIF1A, KDR, KRAS, KRIT1
13MP:00053696.6ACTC1, ANGPT1, FGF2, FLT4, HIF1A, KDR
14MP:00053976.5FGF2, HIF1A, KDR, KRAS, LYVE1, PDPN
15MP:00053876.0ANGPT1, ANGPT2, ANTXR1, FLT4, HIF1A, KDR
16MP:00053845.9ACTC1, ANGPT2, ANTXR1, DIO3, FGF2, HIF1A
17MP:00053785.7ACTC1, ANGPT1, ANTXR1, DIO3, FLT4, HIF1A
18MP:00053765.1ACTC1, ANGPT1, ANGPT2, DIO3, FGF2, FLT4
19MP:00053854.5ACTC1, ANGPT1, ANGPT2, ANTXR1, FGF2, FLT4
20MP:00107684.5ACTC1, ANGPT1, ANGPT2, ANTXR1, DIO3, FGF2

Publications for Hemangioma

About this section

Articles related to Hemangioma:

(show top 50)    (show all 2198)
idTitleAuthorsYear
1
Intrahepatic cholestasis of pregnancy: maternal and fetal outcomes associated with elevated bile acid levels. (25818669)
2015
2
Molecular mechanisms of GLUT4 regulation in adipocytes. (24656589)
2014
3
Case Report: Glioblastoma Multiforme Complicating Familial Cavernous Malformations. (23942770)
2013
4
Whole body application of a potent topical corticosteroid for bullous pemphigoid. (23551654)
2013
5
Bracing in pediatric patients with pectus carinatum is effective and improves quality of life. (23701782)
2013
6
Activated leukocyte cell adhesion molecule soluble form: a potential biomarker of epithelial ovarian cancer is increased in type II tumors. (23169448)
2013
7
Prevalence of insulin resistance and cardiometabolic risk in Korean children and adolescents: A population-based study. (24290751)
2013
8
Identification of multiple subclones in peripheral T-cell lymphoma, not otherwise specified with genomic aberrations. (23342278)
2012
9
Recurrent transitional cell carcinoma of the bladder: A mixed nested variant case report and literature review. (22511434)
2012
10
Involvement of a common progenitor cell in core binding factor acute myeloid leukaemia associated with mastocytosis. (22871474)
2012
11
Diffusion-weighted imaging findings of mucinous carcinoma arising in the ano-rectal region: comparison of apparent diffusion coefficient with that of tubular adenocarcinoma. (22173559)
2012
12
A preliminary study of fluvoxamine maleate on depressive state and serum melatonin levels in patients after cerebral infarction. (22687788)
2012
13
Acute cholecystitis: preoperative CT can help the surgeon consider conversion from laparoscopic to open cholecystectomy. (22332066)
2012
14
Primary actinomycosis of the foot in a patient with neurofibromatosis: a case report. (21571698)
2011
15
Successful management of refractory intracranial hypertension from acute hyperammonemic encephalopathy in a woman with ornithine transcarbamylase deficiency. (20422467)
2010
16
Protein kinase D1 regulates VEGF-A-induced alphavbeta3 integrin trafficking and endothelial cell migration. (20477989)
2010
17
Increasing case numbers of adenovirus conjunctivitis in Germany, 2010. (21087592)
2010
18
Dengue myositis and myocarditis. (20739801)
2010
19
Multivalent-based drug design applied to serotonin 5-HT(4) receptor oligomers. (19199991)
2009
20
Estrogen induces estrogen-related receptor alpha gene expression and chromatin structural changes in estrogen receptor (ER)-positive and ER-negative breast cancer cells. (18174157)
2008
21
Prevalence of leukoplakia, oral submucous fibrosis, papilloma and its relation with stress among green marbles mine laborers, India. (18978707)
2008
22
A syngeneic variance library for functional annotation of human variation: application to BRCA2. (18593900)
2008
23
Uninstrumented in situ fusion for high-grade childhood and adolescent isthmic spondylolisthesis: long-term outcome. (17332099)
2007
24
Corneal edema after aqueous drainage device implantation. (17571002)
2007
25
Identification of 2,3-epoxymethacrylic acid as an intermediate in the metabolism of dental materials in human liver microsomes. (16458349)
2007
26
Adaptive evolution of a stress response protein. (17925851)
2007
27
Neuromyelitis optica]. (17934711)
2007
28
Wernicke encephalopathy: a complication of parenteral nutrition diagnosed by magnetic resonance imaging. (17006085)
2006
29
Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. (16453027)
2006
30
Variation in DNA repair genes ERCC2, XRCC1, and XRCC3 and risk of follicular lymphoma. (16492913)
2006
31
Oral rehabilitation of a young adult with hypoplastic amelogenesis imperfecta: a clinical report. (16399268)
2006
32
Detection of human papillomavirus DNA and p53 codon 72 polymorphism in prostate carcinomas of patients from Argentina. (16307686)
2005
33
Selective COX-2 inhibitors and cardiovascular risk]. (15794303)
2005
34
Neuropathological, biochemical and molecular findings in a glutaric acidemia type 1 cohort. (15689364)
2005
35
Syndecan-1 up-regulated by ephrinB2/EphB4 plays dual roles in inflammatory angiogenesis. (15126321)
2004
36
The ch-TOG/XMAP215 protein is essential for spindle pole organization in human somatic cells. (12569123)
2003
37
Carcinoma ex pleomorphic adenoma: pathologic analysis of 73 cases. (11431714)
2001
38
Co-expression of several human syntaxin genes in neutrophils and differentiating HL-60 cells: variant isoforms and detection of syntaxin 1. (10080545)
1999
39
Evidence for both the nucleus and cytoplasm as subcellular sites of pathogenesis in Huntington's disease in cell culture and in transgenic mice expressing mutant huntingtin. (10434304)
1999
40
Swyer syndrome and 46,XY partial gonadal dysgenesis associated with 9p deletions in the absence of monosomy-9p syndrome. (9718353)
1998
41
Expression of transcripts of interleukin-6 and related cytokines by human breast tumors, breast cancer cells, and adipose stromal cells. (8735608)
1996
42
Quantitation of granulocyte antibodies in sera and determination of their binding sites. (1419798)
1992
43
Tracheobronchomegaly (Mounier-Kuhn syndrome): CT diagnosis. (3258088)
1988
44
Gyrate atrophy of the choroid and retina. Early findings. (3991128)
1985
45
Evidence for abnormal red cell population in refractory sideroblastic anemia. (5443368)
1970
46
Lactate dehydrogenase isoenzymes of jejunal enterobiopsies in non-tropical sprue. (5853057)
1965
47
The Common Causes of Lymphopenia. (16810891)
1950
48
49
50

Variations for Hemangioma

About this section

Expression for genes affiliated with Hemangioma

About this section
Search GEO for disease gene expression data for Hemangioma.

Pathways for genes affiliated with Hemangioma

About this section

Pathways related to Hemangioma according to GeneCards Suite gene sharing:

(show all 36)
idSuper pathwaysScoreTop Affiliating Genes
1
Show member pathways
9.9FLT4, KDR, VEGFA
29.9ANTXR1, KDR, VEGFA
39.9ANTXR1, KDR, VEGFA
4
Show member pathways
9.8ANTXR1, KDR, VEGFA
59.8FGF2, KDR, VEGFA
69.8FGF2, KDR, VEGFA
79.8FGF2, SLC2A1, VEGFA
89.7HIF1A, SLC2A1, VEGFA
99.7HIF1A, SLC2A1, VEGFA
10
Show member pathways
9.6HIF1A, SLC2A1, VEGFA
11
Show member pathways
9.6ANTXR1, FLT4, KDR, KRAS
12
Show member pathways
9.6FGF2, FLT4, KDR, VEGFA
139.6ANGPT1, TEK, VEGFA
149.6FGF2, KDR, PROX1, VEGFA
15
Show member pathways
9.5FLT4, HIF1A, KDR, VEGFA
16
Show member pathways
9.5HIF1A, KDR, SLC2A1, VEGFA
179.5ACTC1, FGF2, KDR
189.4FGF2, FLT4, KDR, KRAS, VEGFA
199.3ANTXR1, KRAS, PTEN, VEGFA
209.3FGF2, KRAS, PTEN, VEGFA
21
Show member pathways
9.2ANGPT1, ANGPT2, KRAS, TEK
229.2HIF1A, KRAS, PTEN, SLC2A1
239.2FGF2, HIF1A, KDR, KRAS, VEGFA
24
Show member pathways
9.1FLT4, KDR, KRAS, PTEN, TEK
259.1DIO3, HIF1A, KRAS, SLC2A1
26
Show member pathways
9.0HIF1A, KRAS, PTEN, SLC2A1, VEGFA
27
Show member pathways
8.9FGF2, FLT4, KDR, KRAS, PTEN, VEGFA
288.8ANGPT1, FGF2, HIF1A, KDR, TEK, VEGFA
298.7FGF2, HIF1A, KRAS, PTEN, SLC2A1, VEGFA
308.7ANGPT1, ANGPT2, HIF1A, SLC2A1, TEK, VEGFA
31
Show member pathways
8.3ANGPT1, ANGPT2, FGF2, FLT4, KDR, KRAS
32
Show member pathways
8.1ANGPT1, ANGPT2, FGF2, FLT4, KDR, KRAS
33
Show member pathways
8.0ANGPT1, ANGPT2, FGF2, FLT4, KDR, KRAS
347.9ANGPT1, ANGPT2, FGF2, FLT4, KDR, KRAS
35
Show member pathways
7.9ANGPT1, ANGPT2, FGF2, FLT4, KDR, KRAS
36
Show member pathways
7.3ANGPT1, ANGPT2, ANTXR1, FGF2, FLT4, HIF1A

GO Terms for genes affiliated with Hemangioma

About this section

Biological processes related to Hemangioma according to GeneCards Suite gene sharing:

(show all 40)
idNameGO IDScoreTop Affiliating Genes
1positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathwayGO:003803310.8KDR, VEGFA
2positive regulation of focal adhesion assemblyGO:005189410.7KDR, TEK
3lymph vessel developmentGO:000194510.6FLT4, PROX1
4positive regulation of macroautophagyGO:001623910.5HIF1A, KDR
5cell migration involved in sprouting angiogenesisGO:000204210.5FGF2, KDR, VEGFA
6positive regulation of transcription from RNA polymerase II promoter in response to hypoxiaGO:006141910.5HIF1A, VEGFA
7negative regulation of blood vessel endothelial cell migrationGO:004353710.5ANGPT2, FGF2
8regulation of transcription from RNA polymerase II promoter in response to hypoxiaGO:006141810.4HIF1A, VEGFA
9positive regulation of receptor internalizationGO:000209210.4ANGPT1, VEGFA
10regulation of synaptic transmission, GABAergicGO:003222810.4KRAS, PTEN
11positive regulation of cellular component movementGO:005127210.3PDPN, VEGFA
12positive regulation of blood vessel endothelial cell migrationGO:004353610.2ANGPT1, FGF2, VEGFA
13positive regulation of phosphatidylinositol 3-kinase signalingGO:001406810.1ANGPT1, KDR, TEK
14positive regulation of protein phosphorylationGO:000193410.1FGF2, TEK, VEGFA
15peptidyl-tyrosine phosphorylationGO:001810810.0FGF2, FLT4, KDR, TEK
16Tie signaling pathwayGO:004801410.0ANGPT1, ANGPT2, TEK
17positive chemotaxisGO:005091810.0ANGPT1, FGF2, VEGFA
18positive regulation of ERK1 and ERK2 cascadeGO:00703749.9FGF2, FLT4, PTEN
19positive regulation of protein kinase B signalingGO:00518979.9ANGPT1, FGF2, TEK
20transmembrane receptor protein tyrosine kinase signaling pathwayGO:00071699.9ANGPT1, FLT4, KDR, TEK
21positive regulation of neuroblast proliferationGO:00020529.9HIF1A, VEGFA
22negative regulation of endothelial cell apoptotic processGO:20003529.8ANGPT1, KDR, KRIT1, TEK
23response to glucoseGO:00097499.8ANGPT2, HIF1A, PTEN
24leukocyte migrationGO:00509009.7ANGPT1, ANGPT2, KRAS
25blood coagulationGO:00075969.6ANGPT1, ANGPT2, TEK, VEGFA
26response to ethanolGO:00454719.6ACTC1, NKX2-1, PTEN
27MAPK cascadeGO:00001659.6ANGPT1, FGF2, KRAS, TEK
28epidermal growth factor receptor signaling pathwayGO:00071739.6ANGPT1, FGF2, KRAS, PTEN
29activation of MAPKK activityGO:00001869.5ANGPT1, FGF2, KRAS, TEK
30positive regulation of angiogenesisGO:00457669.5ANGPT2, FGF2, KDR, TEK, VEGFA
31insulin receptor signaling pathwayGO:00082869.5ANGPT1, FGF2, KRAS, TEK
32dentate gyrus developmentGO:00215429.5PROX1, PTEN
33cellular response to hypoxiaGO:00714569.4HIF1A, PTEN, VEGFA
34vascular endothelial growth factor receptor signaling pathwayGO:00480109.4ANGPT1, FGF2, FLT4, KRAS, VEGFA
35lung developmentGO:00303249.3NKX2-1, PDPN, PROX1, VEGFA
36positive regulation of gene expressionGO:00106289.3FGF2, HIF1A, NKX2-1, VEGFA
37angiogenesisGO:00015259.3FGF2, KDR, KRIT1, TEK, VEGFA
38fibroblast growth factor receptor signaling pathwayGO:00085439.2ANGPT1, FGF2, KRAS, PTEN, TEK
39positive regulation of cell proliferationGO:00082849.1FGF2, FLT4, HIF1A, PROX1, PTEN
40negative regulation of apoptotic processGO:00430668.1ACTC1, ANGPT1, FLT4, HIF1A, KDR, PTEN

Molecular functions related to Hemangioma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1platelet-derived growth factor receptor bindingGO:00051619.8PTEN, VEGFA

Sources for Hemangioma

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet